| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jain Rita | Director | C/O CELLDEX THERAPEUTICS, INC., 53 FRONTAGE ROAD, SUITE 202, HAMPTON | /s/ Sam Martin, attorney-in-fact for Rita I. Jain, M.D. | 09 Jun 2025 | 0001707797 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDX | Non-Qualified Stock Option (right to buy) | Award | $0 | +16,500 | $0 | 16,500 | 05 Jun 2025 | Common Stock | 16,500 | $19.53 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. |